A BioNTech On Friday, he said he hoped to collect data within two weeks to determine whether the vaccine he produced with Pfizer should be reformulated to deal with the matter. to the new look Act covid-19 virusIt was discovered in South Africa.
These companies, if needed, said they hope to have a new vaccine designed for the new variant in about 100 days, B 184.108.40.2069, What happened Noun Omicron. “We are aware of Experts worried and we immediately began investigations with alternative B 220.127.116.119“We expect more data from lab tests in a maximum of two weeks. This data will provide information on whether B.1.1.529 might be a variant that requires modifications to our vaccine if it spreads globally,” BioNTech reported.
Moderna also announced in a statement that it is working on a booster dose designed to measure the new variant and that it is also testing a higher dose than its current booster. Other types of reinforcements that protect against multiple variants are also under study. “A booster dose of an approved vaccine represents the only currently available immune-boosting strategy,” Moderna said.
On Friday, authorities reacted with concern to the new strain, and the European Union and the United Kingdom were among those tightening border controls as scientists try to find out if the virus mutation is vaccine-resistant. The Pfizer and BioNTech have already created versions of their vaccine to address delta and alpha variants and clinical trials are underway.
The new variant was discovered this week in South Africa, but it has already appeared in other African countries, such as Botswana and Zimbabwe, and there are also records of some cases in Hong Kong.
“Hardcore alcohol maven. Hipster-friendly analyst. Introvert. Devoted social media advocate.”